Skip to main content
. Author manuscript; available in PMC: 2023 Mar 17.
Published in final edited form as: J Alzheimers Dis. 2017;56(1):335–349. doi: 10.3233/JAD-160916

Fig. 3.

Fig. 3.

TFP5 inhibits tau and neurofilament hyperphosphorylation. A) Western blots of brain lysates derived from the standard four cohorts of TFP5-treated and untreated mice showing the expression of pNFH (Smi31 antibody) and hyperphosphorylated tau (pTau 404, AT8 antibodies). B) Quantitation of densities using NIH Image J software scanning protocol. Comparison of lanes 3 and 4 show significant reductions in pNFH and phospho tau expression as a consequence of TFP5 treatment. (n = 5; p < 0.05).